A
Antonio Mangieri
Researcher at Vita-Salute San Raffaele University
Publications - 224
Citations - 3323
Antonio Mangieri is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Medicine & Valve replacement. The author has an hindex of 26, co-authored 168 publications receiving 2066 citations. Previous affiliations of Antonio Mangieri include Humanitas University & Imperial College London.
Papers
More filters
Journal ArticleDOI
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation
Sung Han Yoon,Tobias Schmidt,Sabine Bleiziffer,Niklas Schofer,Claudia Fiorina,Antonio J. Muñoz-García,Ermela Yzeiraj,Ignacio J. Amat-Santos,Didier Tchetche,Christian Jung,Buntaro Fujita,Antonio Mangieri,Marcus-André Deutsch,Timm Ubben,Florian Deuschl,Shingo Kuwata,Chiara De Biase,Timothy Williams,Abhijeet Dhoble,Won-Keun Kim,Enrico Ferrari,Marco Barbanti,E. Mara Vollema,Antonio Miceli,Cristina Giannini,Guiherme F. Attizzani,William K.F. Kong,Enrique Gutiérrez-Ibañes,Victor Alfonso Jimenez Diaz,Harindra C. Wijeysundera,Hidehiro Kaneko,Tarun Chakravarty,Moody Makar,Horst Sievert,Christian Hengstenberg,Bernard Prendergast,Flavien Vincent,Mohamed Abdel-Wahab,Luis Nombela-Franco,Miriam Silaschi,Giuseppe Tarantini,Christian Butter,Stephan Ensminger,David Hildick-Smith,Anna Sonia Petronio,Wei Hsian Yin,Federico De Marco,Luca Testa,Nicolas M. Van Mieghem,Brian Whisenant,Karl-Heinz Kuck,Antonio Colombo,Saibal Kar,César Morís,Victoria Delgado,Francesco Maisano,Fabian Nietlispach,Michael J. Mack,Joachim Schofer,Ulrich Schaefer,Jeroen J. Bax,Christian Frerker,Azeem Latib,Raj Makkar +63 more
TL;DR: TAVR using the new-generation devices was associated with improved procedural outcomes in treating patients with pure native AR, and significant post-procedural AR was independently associated with increased mortality.
Journal ArticleDOI
1-Year Outcomes After Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation: Results From the TriValve Registry
Michael Mehr,Maurizio Taramasso,Christian Besler,Tobias Ruf,Kim A. Connelly,Marcel Weber,Ermela Yzeiraj,Davide Schiavi,Antonio Mangieri,Laura Vaskelyte,Hannes Alessandrini,Florian Deuschl,Nicolas Brugger,Hasan Ahmad,Luigi Biasco,Mathias Orban,Simon Deseive,Daniel Braun,Karl-Philipp Rommel,Alberto Pozzoli,Christian Frerker,Michael Nabauer,Steffen Massberg,Giovanni Pedrazzini,Gilbert H.L. Tang,Stephan Windecker,Ulrich Schäfer,Karl-Heinz Kuck,Horst Sievert,Paolo Denti,Azeem Latib,Joachim Schofer,Georg Nickenig,Neil Fam,Stephan von Bardeleben,Philipp Lurz,Francesco Maisano,Jörg Hausleiter +37 more
TL;DR: Transcatheter tricuspid edge-to-edge repair can achieve TR reduction at 1 year, resulting in significant clinical improvement and predictors of procedural failure and 1-year mortality identified here may help select patients who will benefit most from this therapy.
Journal ArticleDOI
Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement
Chekrallah Chamandi,Marco Barbanti,Antonio J. Muñoz-García,Azeem Latib,Luis Nombela-Franco,Enrique Gutiérrez-Ibanez,Gabriela Veiga-Fernandez,Asim N. Cheema,Ignacio Cruz-Gonzalez,Vicenç Serra,Corrado Tamburino,Antonio Mangieri,Antonio Colombo,Pilar Jiménez-Quevedo,Jaime Elízaga,Gerard Laughlin,Dae-Hyun Lee,Bruno García del Blanco,Tania Rodriguez-Gabella,Josep Ramon Marsal,Mélanie Côté,François Philippon,Josep Rodés-Cabau +22 more
TL;DR: The need for PPI post-TAVR was frequent and associated with an increased risk of heart failure rehospitalization and lack of LVEF improvement, but not mortality, after a median follow-up of 4 years.
Journal ArticleDOI
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction
Uri Landes,Uri Landes,John G. Webb,Ole De Backer,Lars Søndergaard,Mohamed Abdel-Wahab,Lisa Crusius,Won-Keun Kim,Christian W. Hamm,Nicola Buzzatti,Matteo Montorfano,Sebastian Ludwig,Niklas Schofer,Lisa Voigtlaender,Mayra Guerrero,Abdallah El Sabbagh,Josep Rodés-Cabau,Leonardo Guimaraes,Ran Kornowski,Pablo Codner,Taishi Okuno,Thomas Pilgrim,Claudia Fiorina,Antonio Colombo,Antonio Mangieri,Hélène Eltchaninoff,Luis Nombela-Franco,Maarten P van Wiechen,Nicolas M. Van Mieghem,Didier Tchetche,Wolfgang Schoels,Matthias Kullmer,Corrado Tamburino,Jan Malte Sinning,Baravan Al-Kassou,Gidon Y. Perlman,Haim D. Danenberg,Alfonso Ielasi,Chiara Fraccaro,Giuseppe Tarantini,Federico De Marco,Guy Witberg,Guy Witberg,Simon Redwood,John Lisko,Vasilis C. Babaliaros,Mika Laine,Roberto Nerla,Fausto Castriota,Ariel Finkelstein,Itamar Loewenstein,Amnon Eitan,Ronen Jaffe,Philipp Ruile,Franz J. Neumann,Nicolo Piazza,Hind Alosaimi,Horst Sievert,Kolja Sievert,Marco Russo,Martin Andreas,Matjaz Bunc,Azeem Latib,Rebecca Govdfrey,David Hildick-Smith,Janarthanan Sathananthan,Mark Hensey,Abdullah Alkhodair,Philipp Blanke,Jonathon Leipsic,David A. Wood,Tamim Nazif,Susheel Kodali,Martin B. Leon,Marco Barbanti +74 more
TL;DR: Redo-TAVR is a relatively safe and effective option for selected patients with valve dysfunction after TAVR, and results are important for applicability of T AVR in patients with long life expectancy in whom THV durability may be a concern.
Journal ArticleDOI
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study.
Nicolas M. Van Mieghem,Azeem Latib,Jan Van der Heyden,Lennart van Gils,Joost Daemen,Todd Sorzano,Jurgen Ligthart,Karin Witberg,Thom L. de Kroon,Nathaniel Maor,Antonio Mangieri,Matteo Montorfano,Peter de Jaegere,Antonio Colombo,Gary S. Roubin +14 more
TL;DR: This first multicenter experience demonstrates rapid and reliable hemostasis and low complication rates with the use of the plug-based MANTA VCD for large-bore arteriotomy closure.